The explanation for the choice of comparator arm {6b}
peripheral neuropathy
PERIPHERAL NEUROPATHY
Patients in the comparator arm will receive placebo. This was chosen as there is no current standard of care in preventing peripheral neuropathy in patients receiving paclitaxel. Two systematic reviews evaluating available evidence regarding therapy for the prevention of paclitaxel-induced peripheral neuropathy did not find any effective preventive strategy [